Skip to contentOrbiMed Capital GP V LLC — Tricida, Inc. insider: 51 transactions · InsiderLensOrbiMed Capital GP V LLC
- Director at Loxo Oncology, Inc. · on record since Aug 12, 2016
- 10% owner at ACETO CORP · on record since Apr 9, 2026
- Director at Nabriva Therapeutics AG · on record since Dec 30, 2016
- 10% owner at Nabriva Therapeutics AG · on record since Dec 30, 2016
- 10% owner at Loxo Oncology, Inc. · on record since Jul 31, 2014
- Director at Dimension Therapeutics, Inc. · on record since Oct 29, 2015
- 10% owner at Dimension Therapeutics, Inc. · on record since Oct 29, 2015
- Director at Adaptimmune Therapeutics PLC · on record since Jan 4, 2016
- Director at Corvus Pharmaceuticals, Inc. · on record since Jun 27, 2016
- 10% owner at Corvus Pharmaceuticals, Inc. · on record since Jun 27, 2016
- 10% owner at Spyre Therapeutics, Inc. · on record since Apr 19, 2016
- Director at Intellia Therapeutics, Inc. · on record since May 13, 2016
- 10% owner at Intellia Therapeutics, Inc. · on record since May 5, 2016
- Director at ZETA ACQUISITION CORP II · on record since Mar 17, 2017
- 10% owner at ZETA ACQUISITION CORP II · on record since Mar 17, 2017
- 10% owner at RHYTHM PHARMACEUTICALS, INC. · on record since Oct 10, 2017
- Director at ARMO BioSciences, Inc. · on record since Jan 30, 2018
- 10% owner at ARMO BioSciences, Inc. · on record since Jan 30, 2018
- Director at Tricida, Inc. · on record since Jun 27, 2018
- 10% owner at Tricida, Inc. · on record since Jun 27, 2018
- 10% owner at INFOSPACE INC · on record since May 9, 2018
- Director at SI-BONE, Inc. · on record since Oct 19, 2018
- Director at INFOSPACE INC · on record since Dec 13, 2018
- Director at COMPEX TECHNOLOGIES INC · on record since Jun 23, 2020
- 10% owner at COMPEX TECHNOLOGIES INC · on record since Jun 23, 2020
- Director at PMV Pharmaceuticals, Inc. · on record since Sep 29, 2020
- 10% owner at PMV Pharmaceuticals, Inc. · on record since Sep 29, 2020
- Director at ACETO CORP · on record since Sep 17, 2020
Insider trading activity of OrbiMed Capital GP V LLC
- Transactions on record
- 51
- since Aug 6, 2014
- Open-market buys
- 12
- $20.1M
- Open-market sells
- 21
- $136.9M
- Companies traded
- 9
- last filing Oct 27, 2025
Figures computed from official regulatory filings — methodology.
Companies where OrbiMed Capital GP V LLC has traded
- PMV Pharmaceuticals, Inc.2 tx · $1.9M · Oct 27, 2025
- Corvus Pharmaceuticals, Inc.9 tx · $10.5M · May 8, 2024
- COMPEX TECHNOLOGIES INC3 tx · $197.3K · May 10, 2022
- Tricida, Inc.12 tx · $19.1M · Nov 17, 2021
- ZETA ACQUISITION CORP II3 tx · $62.5K · Dec 10, 2020
- INFOSPACE INC6 tx · $80.2M · Aug 19, 2020
- Adaptimmune Therapeutics PLC5 tx · $2.7M · Jun 6, 2018
- RHYTHM PHARMACEUTICALS, INC.4 tx · $4.7M · May 24, 2018
- Loxo Oncology, Inc.7 tx · $44.2M · Dec 12, 2017
Track record of OrbiMed Capital GP V LLC
Statistical track record
Free- Open-market buys
- 14
- Last buy
- May 6, 2024
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of OrbiMed Capital GP V LLC
Co-insiders of OrbiMed Capital GP V LLC
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
BARRETT M JAMESAdaptimmune Therapeutics PLC +2
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Oct 27, 2025 | Sell | -1,000,000 | 1.52 USD | $1.5M | SEC |
| May 8, 2024 | BuyD | 1,397,684 | — | — | SEC |
| May 8, 2024 | BuyD | 1,444,085 | 1.73 USD | $2.5M | SEC |
| May 31, 2022 | Sell | -26,253 | 15.93 USD | $418.2K | SEC |
| May 10, 2022 | Buy | 24,447 | 1.60 USD | $39.1K | SEC |
| May 10, 2022 | Buy | 90,712 | 1.56 USD | $141.5K | SEC |
| May 10, 2022 | Buy | 10,200 | 1.63 USD | $16.6K | SEC |
| Nov 17, 2021 | Award | 666,667 | 6.00 USD | $4M | SEC |
| Nov 17, 2021 | AwardD | 666,667 | — | — | SEC |
| Sep 22, 2021 | Sell | -1,109,644 | 6.09 USD | $6.8M | SEC |
| Dec 10, 2020 | OtherD | -21,400 | 0.00 USD | $0 | SEC |
| Dec 10, 2020 | Other | 21,400 | 0.96 USD | $20.5K | SEC |
| Dec 10, 2020 | Sell | -21,400 | 1.96 USD | $41.9K | SEC |
| Aug 19, 2020 | Sell | -43,543 | 108.54 USD | $4.7M | SEC |
| Aug 19, 2020 | Sell | -94,900 | 107.49 USD | $10.2M | SEC |
| Mar 5, 2020 | Sell | -400,000 | 84.42 USD | $33.8M | SEC |
| Mar 5, 2020 | Sell | -25,000 | 84.55 USD | $2.1M | SEC |
| Mar 5, 2020 | Sell | -75,000 | 83.21 USD | $6.2M | SEC |
| Aug 8, 2019 | Buy | 142,656 | 3.51 USD | $500.7K | SEC |
| Apr 5, 2019 | Buy | 225,000 | 36.00 USD | $8.1M | SEC |
| Dec 13, 2018 | Sell | -614,772 | 37.60 USD | $23.1M | SEC |
| Jul 2, 2018 | OtherD | -4,255,319 | — | — | SEC |
| Jul 2, 2018 | OtherD | -6,207,674 | — | — | SEC |
| Jul 2, 2018 | Buy | 368,421 | 19.00 USD | $7M | SEC |
| Jul 2, 2018 | Other | 3,591,194 | — | — | SEC |